Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05508607 · ClinicalTrials.gov registry record
Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 13,319
- Enrollment target
NCT05508607: Completed study, sponsored by Intermountain Health Care.
NCT05508607 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 13,319 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05508607 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 13,319 participants
- Enrollment target
Study Summary
To decrease CDI incidence by implementing an electronic health record-integrated CDI-risk classification tool for Clostridioides difficile infection (CDI) to focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.
Primary Outcome
per-admission rate of hospital-associated CDI, defined as: positive toxin B by enzyme-linked immunoassay or polymerase chain reaction test at least 72 hours after admission
Interventions
- OTHER CDI-risk Classification Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,319 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2022-06-30 |
What the finished NCT05508607 record still lists
NCT05508607 is an observational study that tracks outcomes without assigning an intervention. Its 13,319 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which CDI-risk Classification Tool is the first listed.
NCT05508607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05508607 about?
NCT05508607 is a clinical study titled "Precision Antimicrobial STewardship for Clostridioides DIfficile Prevention". To decrease CDI incidence by implementing an electronic health record-integrated CDI-risk classification tool for Clostridioides difficile infection (CDI) to focus a bundle of antimicrobial stewardship (AMS) CDI prevention recommendations on high-risk patients.
What is the current status of trial NCT05508607?
This trial is currently completed. The enrollment target is 13,319 participants. The study started on 2021-05-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT05508607?
The interventions under investigation include: CDI-risk Classification Tool (OTHER).
Who is sponsoring clinical trial NCT05508607?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- NCT07028398 · 12,990 participants · NA
CMSL Ambulatory Sensitive Condition Nudge Study 2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI